Open Access

Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression

  • Xi Chen1, 3,
  • Hannah V. McCue1,
  • Shi Quan Wong1,
  • Sudhanva S. Kashyap1,
  • Brian C. Kraemer2,
  • Jeff W. Barclay1,
  • Robert D. Burgoyne1 and
  • Alan Morgan1Email author
Molecular Neurodegeneration201510:54

https://doi.org/10.1186/s13024-015-0051-6

Received: 6 October 2015

Accepted: 7 October 2015

Published: 23 October 2015

The original article was published in Molecular Neurodegeneration 2015 10:51

The original version of this article [1] unfortunately contained a mistake. The author list contained a spelling error for the author Hannah V. McCue. The original article has been corrected for this error. The corrected author list is given below:

Xi Chen, Hannah V. McCue, Shi Quan Wong, Sudhanva S. Kashyap, Brian C. Kraemer, Jeff W. Barclay, Robert D. Burgoyne and Alan Morgan

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool
(2)
Geriatrics Research Education and Clinical Center, Seattle Veterans Affairs Puget Sound Health Care System and University of Washington Department of Medicine
(3)
Present Address: Centre for Neurodegenerative Science, Van Andel Research Institute

Reference

  1. Chen X, McCue HV, Wong SQ, Kashyap SS, Kraemer BC, Barclay JW, et al. Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression. Mol Neurodegener. 2015;10:51. doi:10.1186/s13024-015-0046-3.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Chen et al. 2015

Advertisement